Paper27353267
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
Chen X and 7 others. Antimicrob Agents Chemother, 2016. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine. Papers, record 27353267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27353267
- Disease
- HIV infectious disease454 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Deoxyadenine Nucleotides | Major topic |
| Deoxycytosine Nucleotides | Major topic |
| Deoxyguanine Nucleotides | Major topic |
| Emtricitabine | Major topic |
| HIV Infections | Major topic |
| Tenofovir | Major topic |
| Thymine Nucleotides | Major topic |
| Adult | |
| Case-Control Studies | |
| Female | |
| HIV-1 | |
| Humans | |
| Leukocytes, Mononuclear | |
| Linear Models | |
| Male |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 AI007447 | NIAID NIH HHS | United States | T32AI007447 | PubMed and NIH | NIH RePORTER |
| U01 AI084735 | NIAID NIH HHS | United States | U01AI084735 | PubMed and NIH | NIH RePORTER |
| TL1 TR001081 | NCATS NIH HHS | United States | TL1TR001081 | PubMed and NIH | NIH RePORTER |
| K23 AI104315 | NIAID NIH HHS | United States | K23AI104315 | PubMed and NIH | NIH RePORTER |
| U01 AI106499 | NIAID NIH HHS | United States | U01AI106499 | PubMed and NIH | NIH RePORTER |
| UL1 TR001082 | NCATS NIH HHS | United States | UL1TR001082 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01040091 | Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status | Derived from the trial | Yes |
Source ClinicalTrials.gov
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19545170 | Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. | Mol Pharm | 2009 | https://conductscience.org/library/papers/19545170 | PubMed |
| 2 | 19558366 | Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3'-azido-3'-deoxythymidine-dependent cardiotoxicity. | Biochem J | 2009 | https://conductscience.org/library/papers/19558366 | PubMed |
| 3 | 10929917 | Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. | Clin Ther | 2000 | https://conductscience.org/library/papers/10929917 | PubMed |
| 4 | 26813213 | Analyzing Repeated Measurements Using Mixed Models. | JAMA | 2016 | https://conductscience.org/library/papers/26813213 | PubMed |
| 5 | 18839780 | Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools. | Antivir Ther | 2008 | https://conductscience.org/library/papers/18839780 | PubMed |
| 6 | 26733158 | Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction. | Biol Chem | 2016 | https://conductscience.org/library/papers/26733158 | PubMed |
| 7 | 21282432 | Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21282432 | PubMed |
| 8 | 22972843 | Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. | Sci Transl Med | 2012 | https://conductscience.org/library/papers/22972843 | PubMed |
| 9 | 12174032 | Segmented regression analysis of interrupted time series studies in medication use research. | J Clin Pharm Ther | 2002 | https://conductscience.org/library/papers/12174032 | PubMed |
| 10 | 17434879 | CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. | J Antimicrob Chemother | 2007 | https://conductscience.org/library/papers/17434879 | PubMed |
| 11 | 16344116 | HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. | Biochim Biophys Acta | 2005 | https://conductscience.org/library/papers/16344116 | PubMed |
| 12 | 25418535 | Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. | Crit Rev Biochem Mol Biol | 2014 | https://conductscience.org/library/papers/25418535 | PubMed |
| 13 | 17517847 | In vitro interactions between apricitabine and other deoxycytidine analogues. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517847 | PubMed |
| 14 | 12626884 | Relative anti-HIV-1 efficacy of lamivudine and emtricitabine in vitro is dependent on cell type. | J Acquir Immune Defic Syndr | 2003 | https://conductscience.org/library/papers/12626884 | PubMed |
| 15 | 3921544 | Relations between synthesis of deoxyribonucleotides and DNA replication in 3T6 fibroblasts. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3921544 | PubMed |
| 16 | 21715120 | Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. | J Pharm Biomed Anal | 2011 | https://conductscience.org/library/papers/21715120 | PubMed |
| 17 | 23201309 | Selectivity of kinases on the activation of tenofovir, an anti-HIV agent. | Eur J Pharm Sci | 2013 | https://conductscience.org/library/papers/23201309 | PubMed |
| 18 | 20087154 | Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. | AIDS | 2010 | https://conductscience.org/library/papers/20087154 | PubMed |
| 19 | 15047506 | Role of purine nucleoside phosphorylase in interactions between 2',3'-dideoxyinosine and allopurinol, ganciclovir, or tenofovir. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15047506 | PubMed |
| 20 | 19887088 | Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. | Antiviral Res | 2010 | https://conductscience.org/library/papers/19887088 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687587 | Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42687587 | PubMed |
| 37957377 | Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women. | Nat Med | 2023 | https://conductscience.org/library/papers/37957377 | PubMed |
| 36684094 | REverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36684094 | PubMed |
| 34372560 | Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV. | Viruses | 2021 | https://conductscience.org/library/papers/34372560 | PubMed |
| 33020165 | In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/33020165 | PubMed |
| 32392030 | Immunoassay for HIV Drug Metabolites Tenofovir and Tenofovir Diphosphate. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32392030 | PubMed |
| 30199098 | HIV Antiretroviral Pre-Exposure Prophylaxis: Development Challenges and Pipeline Promise. | Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/30199098 | PubMed |
| 28225438 | Levels of Intracellular Phosphorylated Tenofovir and Emtricitabine Correlate With Natural Substrate Concentrations in Peripheral Blood Mononuclear Cells of Persons Prescribed Daily Oral Truvada for HIV Pre-exposure Prophylaxis. | J Acquir Immune Defic Syndr | 2017 | https://conductscience.org/library/papers/28225438 | PubMed |
| 27832147 | Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates. | PLoS One | 2016 | https://conductscience.org/library/papers/27832147 | PubMed |
Drugs4
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| TENOFOVIR DISOPROXIL FUMARATE | CHEMBL1486 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1486 | ChEMBL |
| EMTRICITABINE, (+/-)- | CHEMBL161381 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL161381 | ChEMBL |
| EFAVIRENZ | CHEMBL223228 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL223228 | ChEMBL |
| EMTRICITABINE | CHEMBL885 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL885 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27353267
GET https://conductscience.org/api/papers/v1/27353267/references?page=2